Cite
HARVARD Citation
Nicolini, F. et al. (2015). Nilotinib and peginterferon alfa-2a for newly diagnosed chronic-phase chronic myeloid leukaemia (NiloPeg): a multicentre, non-randomised, open-label phase 2 study. Lancet. 2 (1), pp. e37-e46. [Online].